Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Drugs for Coagulation Disorders
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANTS AND THROMBOLYTIC AGENTS ANTICOAGULANTS AND THROMBOLYTIC AGENTS.
Medications that impact bleeding By Nino Lalaiants Inesa Legrian NYCCT 2012.
ANAESTHESIA AND ANTICOAGULANTS
Vascular Pharmacology
Bleeding time,clotting time, PT, and PTT
Antiplatelet Drugs (Anti-thrombotics)
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
Hemostasis and Blood Coagulation
Anticoagulants Danielle Welschmeyer Medicinal Chemisty Dr. Buynak 27 March 2008.
Clot Lysis and Intravascular Anticoagulants
Anticoagulant, Fibrinolytic and Antiplatelet
ANTICOAGULANT BY :DR ISRAA OMAR.
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
WARFARIN AN OVERVIEW.
BY :DR. ISRAA OMAR.  It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin,which digest fibrin.  The.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
ANTICOAGULANT, THROMBOLYTICS & ANTIPLATELET DRUGS.
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
Drugs for Coagulation disorders. There are a number of different categories of drugs which modify the coagulation process: I. Anticoagulants II. Antiplatelet.
Thrombolytic drugs BY :DR. ISRAA OMAR.
ANTIPLATELET DRUGS.
BY :DR. ISRAA OMAR.  It is initiated concomitantly with coagulation cascade, resulting in the formation of active plasmin,which digest fibrin.  The.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
Anticoagulations and Coagulants
Fibrinolytics, anticoagulants and antiplatelets
To understand blood coagulation tests it is helpful to have a basic understanding of the role of the different blood clotting factors and the coagulation.
ANTIPLATELET DRUGS Learning objectives By the end of this lecture, students should be able to: - describe different classes of anti-platelet drugs and.
ANTIPLATELETES AGENTS BY :DR. ISRAA OMAR. The role of platelets Platelets play a critical role in thromboembolic disease like ischemic heart disease and.
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to to describe different classes of anti-platelet.
Antiplatelet drugs Dr.V.V.Gouripur. Antiplatelet drug An antiplatelet drug is a member of a class of drugs that decreases platelet aggregation and inhibits.
Lots of clots Dr Tom Mabin Vergelegen Mediclinic Somerset West October 16th 2015 Helderberg Cardiac Support Group Seminar.
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Agents Affecting Blood Clotting
Dr. Laila M. Matalqah Ph.D. Pharmacology
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to To describe the role of platelets in.
Prof. Yieldez Bassiouni
Newer Antiplatelet Agents Epifibatide Tirofiban Etc. Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Prof. Abdulrahman Almotrefi
Cardiovascular Disease (CVD) Objectives: Describe the movement of blood through the cardiovascular system Discuss the prevalence of CVD Define the types.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Pharmacology-I (PHR 213) Anti-coagulating agents Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
Anticoagulant Therapy
Drugs Used in Coagulation Disorders Presented by Dr. Sasan Zaeri PharmD, PhD.
Pharmacology-I (PHR 213) Anti-coagulating agents Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
Drugs Used in Coagulation Disorders
Anticoagulant, Antiplatelet, and Thrombolytic Drugs.
Chapter 23 Thrombo-Embolic diseases
Drugs affecting coagulation and dental management
Secondary Haemostasis
Factors against intravascular clotting]
Lec. 12….
Acquired coagulation disorders
ANTICOAGULANT.
Med Chem Tutoring for Anticoagulants, Antiplatelets, and Thrombolytics
The normal haemostasis process involves three stages: 1
Steps in clotting mechanism
PHARMACY TECHNICIAN CHAPTER TWENTY SIX.
ANTICOAGULANTS Dr. A. Shyam Sundar. M.Pharm., Ph.D,
What do I know? What is atherosclerosis?
23 Anticoagulants.
Drugs Affecting Blood.
Anticoagulants.
Prof. Abdulrahman Almotrefi
FIBRINOLYTIC DRUGS VIJAYA LECHIMI RAJ.
Presentation transcript:

Anticoagulants Course: Pharmacology I Course Code: PHR 213 Course Instructor: Sabiha Chowdhury Lecturer Department of Pharmacy BRAC University

Blood Coagulation Process Haemostasis (arrest of blood loss) and blood coagulation involve complex interactions between the injured vessel wall, platelets and coagulation factors.

Anticoagulants These are drugs used to reduce the coagulability of blood. They may be classified into: I. Used in vivo A. Parenteral anticoagulants Heparin, Low molecular weight heparins (ii) Direct thrombin inhibitors: Lepirudin, Bivalirudin, Argatroban B. Oral anticoagulants (i) Coumarin derivatives: Bishydroxycoumarin (dicumarol), Warfarin sod (ii) Indandione derivative: Phenindione. II. Used in vitro A. A. Heparin B. Calcium complexing agents: Sodium citrate Sodium oxalate Sodium edetate

Heparin

Antiplatelet Heparin in higher doses inhibits platelet aggregation and prolongs bleeding time. Antiplatelet drugs are the agents which can interfere with the platelet aggregation and platelet adherence and thus inhibit thrombus formation. E.g. aspirin, dihydrochloropuin, dextran. Aspirin is used in lower dose 75mg/day for heart patient but normally 300 mg/tablet Therapeutic indications: Cerebrovascular accident/ brain stroke Venous thrombosis Chronic hypertension Pulmonary embolism Coronary Thrombosis Atherosclerosis Angina Pectoris

Heparin Antagonists Protamine sulfate: It is a strongly basic, low molecular weight protein obtained from the sperm of certain fish. Given I.V. It neutralises heparin weight for weight, i.e. 1 mg is needed for every 100 U of heparin. However, it is needed infrequently because the action of heparin disappears by itself in a few hours, and whole blood transfusion is needed to replenish the loss when bleeding occurs. Protamine is more commonly used when heparin action needs to be terminated rapidly, e.g. after cardiac or vascular surgery. In the absence of heparin, protamine itself acts as a weak anticoagulant by interacting with platelets and fibrinogen. Being basic in nature it can release histamine in the body. Hypersensitivity reactions have occurred. Rapid i.v. injection causes flushing and breathing difficulty. PROTA, PROTAMINE SULFATE 50 mg in 5 ml inj.

Uses of Anticoagulants 1. Deep vein thrombosis (DVT) and pulmonary embolism (PE) 2. Myocardial infarction (MI) 3. Unstable angina 4. Rheumatic heart disease; Atrial fibrillation (AF) 5. Cerebrovascular disease 6. Vascular surgery, prosthetic heart valves, retinal vessel thrombosis, extracorporeal circulation, haemodialysis 7. Defibrination syndrome

Oral Anticoagulants (e.g. dicoumarol/ warferin) Mechanism of Action of oral anticoagulants: Dicoumarol has structural similarity with Vit-K. So this drug competitively inhibits Vit-K-epoxide reductase enzyme which is responsible for conversion of Vit-K epoxide into Vit-K. Dicoumarol (-) Vitamin-K epoxide reductase Vit-K epoxide Vitamin K Activation of factor VIII, IX, X Blood coagulation

Oral Anticoagulants (Cont.) Vitamin-K epoxide in time causes activation of coagulation factors VIII, IX, and X. So inhibition of Vit-K-epoxide conversion results in anti coagulant activity of the drug. Therapeutic Indications of Oral anti-coagulant: -Venous thrombosis -Pulmonary embolism -Acute MI patient -Ischemic heart disease/ Angina Pectoris patient -Brain stroke/ Cerebral infraction patient -Arterilal embolism -Frost bite -Acute Gangrena